Cure My Disease

Don't miss your cure!

 Log in / Sign up

Home antibody tests put to the test: can you read your own COVID-19 result?

NCT ID NCT04393961

Diagnosis Sponsor: ProofPilot Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers are studying whether people can accurately use a rapid COVID-19 antibody test at home. Participants in New York City who have recovered from or suspect they had COVID-19 take the finger-prick test themselves and photograph the result for a doctor to check. The study also tracks how receiving the test result changes participants' social distancing behavior and anxiety over eight weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette, a finger-prick antibody test
What this could lead to
If the test works at home, people could check their own COVID-19 antibody status without visiting a clinic, which may help them make informed decisions about social distancing.
What could go wrong
This is a small usability study, not a large trial of test accuracy. People may misread their own results, and the test itself has not been fully reviewed by the FDA. Results may not apply to other antibody tests or to people outside New York City.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Started

Apr 2020

Finished

Aug 2020

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Reside and Currently in New York City * Does not have a blood clotting disease * Is not abnormally queasy about taking a blood sample * Not on any blood thinning medications * Able to consent * Willingness to take a blood sample * Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronavirus are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronavirus COVID -19 COVID19

Contacts and locations

Locations

  • ProofPilot Online App (https://p.proofpilot.com)

    New York, New York, 10003, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.